Rising Hospitalization Rates Driving Growth In Intravenous Fluid Transfer Drug Device Market Is Supporting Expansion In The Intravenous Fluid Transfer Drug Devices Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Intravenous Fluid Transfer Drug Devices Market Between 2026 And 2030?
The intravenous fluid transfer drug devices market has experienced substantial growth in recent years. It is projected to expand from $7.85 billion in 2025 to $8.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to factors such as reliance on conventional iv sets, increasing hospital and clinical procedures, limited availability of smart infusion devices, growing awareness of iv therapy benefits, and adoption of pvc infusion bags.
The market for intravenous fluid transfer drug devices is projected to experience substantial expansion in the coming years. This market is anticipated to reach $10.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth is driven by several factors, including technological advancements in smart infusion pumps, increased demand for pre-filled and multi-chamber infusion bags, broader applications in oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Key trends expected during this period involve the growing acceptance of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a rise in the need for needleless connectors and safety IV sets, the broadened application of IV therapy in chronic and critical care, and an increased emphasis on sterility, accuracy, and flow control.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Strong Drivers Are Impacting The Intravenous Fluid Transfer Drug Devices Market Growth?
The intravenous fluid transfer drug device market is anticipated to expand due to an increase in hospitalization rates in the future. This increase in hospitalizations is influenced by an aging demographic, the prevalence of chronic illnesses, improved diagnostic capabilities, and greater access to healthcare, along with lifestyle-associated diseases and breakthroughs in medical technology. Fluid transfer systems play a crucial role in ensuring the accurate and regulated delivery of fluids and medications straight into the bloodstream of patients admitted to hospitals. As an illustration, data from GOV.UK, a US-based government agency, indicated that in March 2023, COVID-19 hospital admissions in England showed a slight increase to 10.62 per 100,000 in 2023, whereas ICU/HDU admissions remained low at 0.28 per 100,000. Minor rises were observed across most regions, with admission rates generally consistent across various age demographics. Consequently, an escalating hospitalization rate is poised to boost the growth of the intravenous fluid transfer drug device market.
How Is Segmentation Applied In The Intravenous Fluid Transfer Drug Devices Market Segment Analysis?
The intravenous fluid transfer drug devices market covered in this report is segmented –
1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors
Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices
Which Trends Are Contributing To Changes In The Intravenous Fluid Transfer Drug Devices Market?
Leading companies within the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems. These systems integrate features like auto-identification, aiming to boost accuracy, enhance patient safety, and streamline the process of administering fluids and medications. Auto-identification in infusion systems functions by automatically verifying and matching medications to the correct patient, typically utilizing barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, obtained FDA 510(k) clearance for its updated BD Alaris Infusion System. The BD Alaris Infusion System includes refreshed hardware for its Point-of-Care Unit (PCU), featuring large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also introduces an advanced software version with improved cybersecurity and interoperability features, allowing for seamless integration with widely used electronic medical record (EMR) systems, thereby supporting smart and connected healthcare.
Who Are The Companies Participating In The Intravenous Fluid Transfer Drug Devices Market Environment?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG
Get The Full Intravenous Fluid Transfer Drug Devices Market Report:
Where Is The Intravenous Fluid Transfer Drug Devices Market Primarily Concentrated By Region?
North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Intravenous Fluid Transfer Drug Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company
Neurovascular Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report
Peripheral Iv Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report
Central Venous Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
